// App-Quantinova.ai

P068/P068 : Analysis of Infection in Younger and Older Patients with Multiple Sclerosis Treated with Cladribine Tablets who had Grade ≥3 Lymphopenia

Researchers

Presenter

  • P. K. Coyle

Principal Investigators

  • G. Giovannoni

  • P. Vermersch

  • B. Walker

  • J. Aldridge

  • A. Nolting

  • A. Galazka

  • C. Lemieux

  • T. P. Leist

Medical Centers

  • Department of Urology, Stony Brook University Medical Center, Stony Brook, NY

  • Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom

  • University of Lille, Lille, FRANCE

  • Duke University College of Medicine, Durham, NC

  • EMD Serono Research & Development Institute, Inc., Billerica, MA, USA; a business of Merck KGaA, Darmstadt, Germany

  • Merck KGaA, Darmstadt, GERMANY

  • EMD Inc., Mississauga, ON, Canada, an affiliate of Merck KGaA, Darmstadt, Germany, Mississauga, ON, CANADA

  • Thomas Jefferson University, Philadelphia, PA

Locations

  • United States

  • United Kingdom

  • France

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

  • Lymphocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved